Stockreport

Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Diseas...

Alpha Tau Medical Ltd. - Ordinary Shares  (DRTS) 
PDF Alpha Tau Medical Ltd. Mon, February 3, 2025 at 2:30 PM GMT+1 4 min read In This Article DRTS DRTSW Alpha Tau Medical Ltd. JERUSALEM, Feb. 03, 2025 (GLOBE [Read more]